Blood products are critical hospital resources with demand shaped by elective surgery, trauma, oncology treatment, and ongoing transfusion dependence. Volatility in daily use can create simultaneous risks of shortage and expiry-related wastage. Current inventory management often relies on par-level reordering and manual review of limited indicators. Such approaches may not anticipate daily demand shifts arising from multiple clinical drivers at the same time. This article develops a conceptual predictive model for forecasting daily blood product demand in tertiary hospitals. The model integrates surgical schedules, trauma admission patterns, transfusion history, oncology treatment plans, and inventory depletion data. The proposed approach uses time-series regression or gradient-boosted tree modelling trained on historical transfusion and hospital operations data. The model would output expected demand by blood product type for the next 24 hours. Conceptually, the model would provide a daily product-specific demand forecast with uncertainty bounds. It could flag days of expected high use driven by complex surgical lists, trauma activity, or planned oncology transfusion support. The model could support proactive, data-driven blood inventory management. It may help reduce emergency ordering, improve preparedness, and limit avoidable wastage.
Blood product inventory management in tertiary hospitals requires a balance between immediate availability for life-threatening haemorrhage and avoidance of expiry-related wastage. Red blood cells, platelets, plasma, and cryoprecipitate differ in storage constraints, clinical indications, and replenishment patterns, making daily demand difficult to manage with a single static rule. Recent work in blood supply forecasting and inventory optimisation has shown that modelling demand and ordering jointly could support more reliable transfusion service planning [1, 2]. This dual challenge is especially acute in hospitals with high surgical, trauma, and oncology workloads, where predictable and unpredictable demand streams converge.
Current forecasting in many blood banks depends heavily on recent average use, par-level thresholds, and manual awareness of major clinical activity. These methods may underrepresent specific predictors such as cardiac surgery schedules, transplant activity, orthopaedic cases, and chemotherapy-related cytopenias. Studies of perioperative transfusion prediction show that procedure characteristics, patient condition, and operative context can provide clinically meaningful signals before blood products are issued [3-9]. A daily forecasting model could therefore move beyond average usage by incorporating planned care pathways into operational demand planning.
Electronic health record integration creates an opportunity to extract real-time clinical schedules, patient-level transfusion history, and blood bank workflow data for predictive modelling. Machine learning methods have already been applied to platelet demand, intraoperative transfusion, and blood inventory ordering, suggesting that structured hospital data can support more adaptive forecasting [10-13]. Patient-specific transfusion histories are particularly relevant for chronically transfused haematology and oncology patients, while issue and reservation logs can describe how demand materialises operationally [11, 14]. These data streams could allow a model to forecast not only expected use but also the clinical reasons behind expected demand.
This article proposes a machine learning model that produces a daily blood product demand forecast by synthesising planned and historical clinical predictors alongside inventory behaviour. The model is conceptual rather than experimental, and it is intended to describe how transfusion service data could be organised, processed, interpreted, and deployed. Prior research on blood demand forecasting, perioperative transfusion prediction, trauma transfusion modelling, and chemotherapy-induced cytopenias provides the rationale for integrating these predictors into a single hospital-level architecture. The central premise is that daily demand is best treated as a product-specific operational outcome shaped by both scheduled care and stochastic emergency use.
Table 1 conceptualises how distinct categories of demand drivers contribute differently to predictability, modelling strategy, and operational decision-making.
Table 1. Comparative Structure of Planned, Stochastic, and Recurrent Drivers of Blood Product Demand
Demand Driver Category | Core Data Sources | Temporal Predictability | Mechanistic Role in Demand Formation | Modelling Representation | Operational Implication |
Planned Procedural Demand | Surgical schedules, procedure codes, preoperative labs | High (scheduled in advance) | Determines expected transfusion probability based on procedure type and patient condition | Deterministic aggregation with probabilistic weighting by procedure risk | Enables proactive cross-matching and pre-allocation of components |
Recurrent Chronic Demand | Oncology treatment plans, transfusion history | Moderate to high (cycle-based but variable) | Reflects ongoing transfusion dependence due to cytopenia or marrow failure | Patient-level longitudinal features aggregated to daily demand signals | Supports anticipatory platelet and RBC inventory positioning |
Stochastic Emergency Demand | Trauma admissions, ED activity, MTP activation logs | Low (unpredictable onset) | Introduces sudden high-volume demand variability | Probabilistic modelling with uncertainty distributions | Requires buffer stock and conservative inventory policies |
Operational Feedback Demand | Inventory depletion rates, reservation logs, expiry patterns | Moderate (reactive but patterned) | Captures how demand materialises through workflow and stock movement | Time-series features reflecting velocity and deviation from baseline | Aligns forecast with real-time stock pressure and wastage risk |
Hybrid Interaction Effects | Combined clinical and inventory signals | Variable | Interaction between planned and unplanned drivers amplifying demand peaks | Nonlinear interactions captured via machine learning models | Identifies surge days requiring escalation in ordering strategy |
Blood product use in tertiary hospitals reflects a mixture of routine, urgent, and episodic clinical need across red blood cells, platelets, plasma, and cryoprecipitate. Red blood cell use is often associated with surgery, bleeding, anaemia, and critical illness, while platelet demand is strongly influenced by haematology-oncology care and procedural bleeding risk. Platelet ordering is particularly sensitive to short shelf life, changing clinical schedules, and patient-level thresholds, which makes it an important target for predictive inventory planning [10-13, 15-20]. Demand forecasting must therefore distinguish product type, clinical indication, and timing rather than treating all blood components as interchangeable units.
Surgical schedules are a natural source of planned demand signals because procedure type, anticipated blood loss, preoperative haemoglobin, and institutional ordering protocols shape transfusion probability. Machine learning studies in perioperative settings suggest that structured preoperative and intraoperative data could help predict transfusion need across cardiac, orthopaedic, liver transplant, and general surgical populations [10-13, 21-23]. For a daily hospital demand model, surgical information would be aggregated from individual case-level predictors into a product-specific estimate for the next ordering cycle. This approach would allow blood banks to prepare for high-risk operating lists while preserving specialist review and manual override.
Trauma demand differs from elective surgical demand because massive transfusion protocol activation can occur suddenly and may require rapid issue of multiple components. Predictive modelling of massive transfusion in trauma has explored how early clinical indicators and registry variables could identify patients likely to require high-volume blood support [24-26]. A hospital demand model could incorporate recent trauma admissions, emergency department activity, and activation patterns as probabilistic rather than fixed inputs. This would help express trauma demand as uncertainty around expected use rather than as a deterministic daily total.
Oncology and haematology services create recurring transfusion demand through chemotherapy-induced anaemia, thrombocytopenia, marrow failure, and supportive care protocols. Predictive models for chemotherapy-induced thrombocytopenia indicate that treatment regimen, patient characteristics, and disease context can inform expectations about future cytopenic risk [27-29]. In a blood demand forecasting model, oncology treatment calendars and transfusion history could identify patients likely to require scheduled platelet or red cell support. These features would make planned oncology demand visible to the blood bank before orders are placed.
Machine learning and time-series approaches have been applied to blood demand forecasting, platelet ordering, and supply-demand matching, offering a basis for integrated hospital inventory decision support. Prior studies have combined statistical modelling, machine learning, and inventory optimisation to connect demand forecasts with order quantities and stock management decisions [1, 2, 10, 21-23]. Broader predictive analytics in transfusion medicine also includes donor prediction, transfusion risk modelling, and red blood cell quality analytics, demonstrating the range of data-driven methods relevant to blood services [30, 31]. For hospital operations, the key design challenge is to translate forecasts into interpretable and auditable actions within existing transfusion workflows.
The proposed predictive pipeline would ingest daily data from the surgical scheduling system, trauma registry, oncology electronic health record flowsheets, transfusion service logs, and blood bank inventory system. Each source would contribute time-stamped signals describing expected clinical activity, recent unplanned demand, patient-level transfusion dependence, and current stock movement. The model would then generate a product-specific forecast for the next 24 hours, aligned with blood bank ordering and reservation workflows [1, 2, 23]. This architecture treats demand forecasting as an operational process linking clinical activity to component availability rather than as a stand-alone statistical exercise.
Figure 1 illustrates the hierarchical architecture of the proposed predictive pipeline integrating clinical, operational, and inventory-derived signals into a unified daily blood product demand forecast.
Figure 1. Hierarchical Predictive Pipeline for Daily Blood Product Demand Forecasting in Tertiary Hospitals
Core input features would include the number and type of scheduled surgeries, estimated transfusion probability by procedure category, recent trauma admissions, active oncology patients with planned treatment or transfusion dates, historical transfusion behaviour per patient, and current inventory level by component. Surgical models indicate that procedure context and patient status can inform transfusion risk, while platelet demand models show the value of patient-specific features in forecasting component need [3-9, 15-20]. Trauma features would be represented through recent emergency activity and activation patterns rather than assumed fixed demand [24-26]. Inventory features would describe depletion behaviour, reservation pressure, and issue frequency to connect predicted clinical need with operational stock movement [1, 10].
The model should operate on a daily cadence that matches blood bank ordering cycles while remaining flexible enough to refresh when key clinical schedules change. It should be robust to missing or delayed data, especially when elective surgery schedules are incomplete, oncology treatment dates are revised, or trauma activity changes rapidly. Interpretability is essential because transfusion service staff must understand why the model anticipates high demand and when manual override is appropriate [11-13, 23]. The design should also flag forecasted surge days so that blood bank managers can distinguish routine replenishment from days requiring conservative preparedness.
Surgical schedule feature extraction would convert operating room lists into daily predictors, including procedure codes, surgical specialty, scheduled start time, expected blood loss category, and patient preoperative haemoglobin status. Procedure-specific transfusion models in cardiac, orthopaedic, transplant, liver, and general surgery suggest that such variables can be useful for anticipating perioperative blood use [3-9, 15-20]. These case-level predictors would be aggregated into expected daily demand signals for red blood cells, plasma, platelets, and cryoprecipitate. The resulting feature set would support proactive cross-match and reservation planning while preserving clinician review for high-risk cases.
Trauma features would include emergency admissions, shock or activation indicators, and recent massive transfusion protocol activity, represented as probabilistic drivers of unplanned demand. Transfusion history features would summarise recurrent patient-level use, such as recent red cell or platelet support, chronic transfusion patterns, and proximity to prior component issue. Oncology features would be derived from treatment calendars, expected cytopenia timing, and supportive care plans, reflecting the predictable component of chemotherapy-associated transfusion need [14, 27-29]. Together, these predictors would allow the model to combine sudden emergency demand with recurring and planned transfusion dependence [24-26].
Inventory depletion features would describe current stock by product type and blood group, recent issue velocity, reservation pressure, near-expiry stock, and wastage risk. Prior work linking demand forecasting to inventory ordering shows that forecast outputs become more useful when they are connected to stock levels and replenishment decisions [1, 2, 10]. Seasonality, weekday effects, and recent deviations from expected use would help the model recognise operational patterns that are not fully explained by clinical schedules. These features would enable the forecast to represent not only expected clinical demand but also the pace at which available inventory is being consumed.
A gradient-boosted tree model or a time-series regression model with exogenous clinical regressors would be appropriate for this conceptual architecture. Gradient-boosted trees could capture nonlinear interactions among surgical case mix, oncology treatment activity, trauma admissions, and current inventory status, while time-series models could represent recurring temporal structure in daily component use. Prior transfusion and blood inventory studies support the relevance of machine learning, statistical forecasting, and integrated inventory optimisation for this type of structured hospital problem [1-3, 10, 21-23]. The selected model should prioritise interpretability, stability, and clinical plausibility rather than only statistical fit.
The input feature vector would combine continuous variables such as recent depletion rates and expected surgical blood use with categorical variables such as product type, surgical specialty, blood group, and admission pathway. Continuous features could be standardised or transformed for model stability, while categorical features could be encoded so that product-specific patterns remain visible to the algorithm. Missing values from weekend schedules, delayed oncology updates, or incomplete emergency data would require explicit handling rather than silent exclusion, because these absences may themselves carry operational meaning [11, 21, 22]. Preprocessing should preserve auditability so that blood bank staff can trace how each forecast was generated from source data.
The model would output daily demand forecasts by blood product type, with the option to express results as rounded unit expectations and prediction intervals for 24-, 48-, and 72-hour horizons. Product-specific outputs are important because red blood cells, platelets, plasma, and cryoprecipitate differ in storage duration, clinical urgency, and replenishment constraints. Forecasts could be displayed alongside recent use, scheduled high-risk activity, and current inventory position to support ordering decisions within transfusion service workflows [1, 10, 23]. The output should remain advisory, allowing transfusion medicine specialists to adjust decisions based on contextual information not captured in the model.
Trauma-related demand should be represented as a probabilistic component because emergency haemorrhage and massive transfusion activation cannot be scheduled in advance. Prior trauma prediction studies suggest that early clinical and admission signals could inform the likelihood of high-volume transfusion without eliminating uncertainty [24-26]. The model would therefore output a likely demand range rather than a single fixed estimate for trauma-driven use. This approach would help blood banks prepare conservatively while recognising that not every high-risk trauma signal becomes sustained component demand.
Elective surgical demand can change when cases are added, delayed, cancelled, or converted to more complex procedures. A useful forecasting system would refresh when live operating room schedules change, allowing the predicted demand profile to adjust before products are cross-matched or reserved. Perioperative transfusion prediction studies indicate that procedure type, patient status, and operative context are relevant signals, so schedule updates should directly alter the forecast [3-9, 15-20]. In practice, the model would support repeated intra-day review rather than a single static morning estimate.
High-uncertainty forecasts should be flagged when multiple drivers are unstable, such as complex surgery lists, recent trauma admissions, or oncology patients with uncertain transfusion timing. Prediction intervals would be used conceptually to distinguish routine expected use from days requiring cautious inventory positioning. Prior work on blood demand forecasting and platelet ordering supports linking forecasts to operational decisions, but uncertainty must remain visible to avoid overconfidence [1, 10, 23]. A conservative alert could prompt blood bank managers to review stock, reservations, and supplier communication before demand materialises.
Interpretability is essential because transfusion service staff must understand why the model expects increased demand before acting on its recommendation. Explanation methods could identify whether forecasted platelet demand is driven by haematology patients, cardiac surgery, recent depletion, or a combination of these factors. Patient-level platelet modelling and broader transfusion analytics show that machine learning outputs are more useful when they can be connected to clinically recognisable drivers [11-13, 30]. Explanations would support trust, manual override, and governance by making the forecast auditable.
The model should be embedded in a transfusion service dashboard that displays predicted demand beside current stock, reservations, near-expiry units, and recommended order review. Such integration would connect forecasting to blood bank workflow rather than leaving predictions as isolated analytics outputs. Studies combining demand forecasting with inventory ordering show that operational value depends on linking predicted use to actionable replenishment decisions [1, 2, 10]. Colour-coded alerts could indicate when forecasted demand is expected to exceed available stock or when wastage risk requires redistribution.
Automated order recommendations would translate the demand forecast into a proposed product order list that accounts for lead time, minimum stock thresholds, expected depletion, and component shelf life. The recommendation should remain subject to transfusion medicine specialist approval because clinical context and supplier constraints may not be fully captured in source data. Prior work on red blood cell ordering and platelet inventory management supports the conceptual value of connecting forecasts to ordering decisions [1, 2, 10]. The model would therefore function as decision support rather than autonomous inventory control.
Table 2 links forecast outputs and uncertainty signals to actionable blood bank decisions, emphasising the operational interpretation of predictive analytics.
Table 2. Analytical Mapping between Model Outputs, Uncertainty Signals, and Blood Bank Decision Actions
Model Output Type | Interpretation Layer | Uncertainty Characteristic | Decision Pathway | Risk if Ignored | Recommended Operational Response |
Point Forecast (Mean Demand) | Baseline expected usage per product | Low to moderate | Routine inventory replenishment planning | Understocking or overstocking if misestimated | Align daily orders with expected depletion |
Prediction Interval (Range) | Bounds of plausible demand variation | Explicitly quantified | Risk-aware inventory positioning | Overconfidence in point estimate leading to shortages | Maintain buffer stock proportional to interval width |
Surge Flag (High-Demand Alert) | Identification of atypical demand drivers | High (multi-factor instability) | Escalated review and contingency planning | Failure to prepare for peak demand events | Increase stock thresholds and review supplier options |
Driver Attribution (Explainability Output) | Identification of contributing factors (e.g., surgery, oncology, trauma) | Context-dependent | Clinical validation and manual override | Misinterpretation of model output | Engage transfusion specialists for case-level review |
Inventory Stress Indicator | Alignment of forecast with current stock and depletion | Dynamic and time-sensitive | Immediate operational intervention | Stockout or wastage due to misalignment | Redistribute stock or expedite orders |
Temporal Forecast Horizon (24–72h) | Short-term planning window | Increasing uncertainty with horizon length | Multi-day procurement and logistics planning | Delayed response to evolving demand | Stage orders and monitor updates iteratively |
Closed-loop learning would compare actual daily issue, reservation, wastage, and emergency order patterns with the model’s prior forecast. This feedback could guide periodic recalibration as surgical practice, oncology protocols, trauma volume, or blood bank workflows change. Blood demand forecasting studies and transfusion analytics reviews emphasise that models should adapt to changing operational environments rather than remain fixed after initial development [21-23]. Continuous monitoring would also help identify when data latency, workflow changes, or coding practices begin to degrade forecast reliability.
The model should be evaluated using standard forecast error measures such as mean absolute error, root mean square error, and mean absolute percentage error by product type, without relying on any single metric alone. Prediction interval coverage should also be assessed because uncertainty is operationally meaningful for trauma, surgery, and platelet demand. Prior blood demand forecasting and platelet ordering research provides a basis for evaluating both point forecasts and decision-oriented outputs [1, 10, 21]. Evaluation should focus on whether the model would support safer and more efficient inventory decisions than routine par-level review.
Temporal validation should use rolling or forward-looking splits so that future demand is never used to inform past forecasts. A silent prospective run would allow the model’s recommendations to be compared with existing blood bank practice before any operational changes are made. Machine learning studies in transfusion and perioperative prediction show the importance of validation designs that reflect real clinical deployment rather than retrospective convenience alone [3, 7, 14]. This strategy would help determine whether the model remains credible under changing schedules, admissions, and inventory conditions.
Operational impact should be assessed through stockout events, expiry-related wastage, emergency courier orders, reservation pressure, and staff time spent on daily ordering review. These outcomes reflect whether the forecast improves blood bank work rather than only whether predicted demand approximates observed use. Inventory optimisation studies suggest that forecast value depends on downstream ordering, replenishment, and supply-demand matching processes [1, 2, 23]. Evaluation should therefore combine predictive accuracy with practical measures of transfusion service resilience.
The proposed model depends on timely access to surgical schedules, trauma indicators, oncology plans, transfusion history, and inventory records. Surgical schedules may change after extraction, trauma admissions are difficult to anticipate beyond short horizons, and oncology plans may not perfectly predict actual cytopenia or transfusion timing. Prior work in perioperative, trauma, and chemotherapy-related prediction suggests that these signals are useful but inherently incomplete [3-9, 14-20, 24-29]. Data latency must therefore be treated as a core modelling limitation rather than a minor technical issue.
A model developed for a high-volume tertiary hospital may not transfer directly to smaller hospitals, regional centres, or institutions with different trauma, surgery, oncology, and supplier profiles. Local transfusion thresholds, surgical case mix, platelet practices, and inventory policies can alter both demand patterns and decision consequences. Prior studies across blood demand forecasting, transfusion prediction, and donor analytics show that machine learning systems are shaped by the populations and workflows from which their data are drawn [1, 2, 21-23, 30, 31]. Multi-centre validation would therefore be necessary before broad deployment.
A machine learning model for daily blood product demand forecasting could help tertiary hospitals integrate clinical schedules, transfusion history, oncology treatment activity, trauma patterns, and inventory depletion into a single decision-support framework. Such a model would produce product-specific forecasts aligned with blood bank ordering cycles.
Its key strength would be the integration of scheduled and unscheduled demand drivers into an interpretable operational forecast. Product-specific outputs and uncertainty estimates could help staff distinguish routine replenishment from days requiring heightened preparedness.
Important challenges would remain in real-time data integration, modelling trauma surges, handling schedule changes, and maintaining trust among transfusion service staff. Cross-site transferability would also require careful attention because hospital case mix and blood bank workflows differ substantially.
Future work should prioritise multi-centre validation and pilot implementation within blood bank information systems. The goal should be a safe, auditable, and clinically supervised forecasting tool that improves preparedness while reducing avoidable wastage.
None
None
None
None
Open Access The author(s) retain copyright. This article is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. It may be shared and adapted for non-commercial purposes with appropriate attribution, an indication of changes, and distribution of adaptations under the same license. Third-party material may be subject to separate terms identified in its credit line. View the license at https://creativecommons.org/licenses/by-nc-sa/4.0/.
Clinical Intelligence Research Press
